Archives

Participants needed for study into whether good oral health can slow memory loss

22 January 2024

A study into whether brushing teeth daily can slow memory loss in people with early stage Alzheimer’s disease is recruiting participants through Join Dementia Research. The MySmile study, led by the University of Bristol and supported by the National Institute for Health and Care Research (NIHR), is recruiting people aged 60 and over with either […]

Research into the link between Alzheimer’s disease and Down’s syndrome

16 January 2024

People with Down’s syndrome have an increased risk of developing Alzheimer’s disease. This is because most people with Down’s syndrome will have clumps of amyloid and tau proteins in their brains by the age of 40 – these are believed to cause Alzheimer’s disease. Two thirds of people with Down’s syndrome develop Alzheimer’s by the […]

Celebrating World Alzheimer’s Month 2023

29 September 2023

World Alzheimer’s Month took place in September. This year’s theme was ‘Never too early, never too late’, which focused on raising awareness of risk factors for Alzheimer’s disease and potentially preventing the onset of dementia. Throughout the month, Join Dementia Research celebrated patients, members of the public, healthcare professionals and researchers involved in research. Here […]

Why you should get involved in dementia research: Rianna’s story

22 September 2023

A Sussex woman has spoken about losing her grandfather to dementia and how this inspired her to get involved in research. Rianna Patterson, of Hastings, lost her grandfather, Terry Vidal, to dementia in 2013. Following his death, she has been involved in dementia research. This included working with a National Institute for Health and Care […]

Former PCSO volunteers for dementia research after diagnosis

26 July 2023

A former Police Community Support Officer (PCSO) has spoken about how volunteering for studies through Join Dementia Research has given him a sense of purpose after his Alzheimer’s disease diagnosis.  Peter Middleton from Northamptonshire was diagnosed with early onset Alzheimer’s disease in 2018, aged 64.  Diagnosis Peter said: “I had been a Police Community Support […]

Drug donanemab hailed as breakthrough in treat Alzheimer’s disease following trial

19 July 2023

A new drug has been hailed as a scientific breakthrough in treating Alzheimer’s disease, following the publication of final trial results in the medical journal, JAMA.  The findings show donanemab can successfully slow down decline in memory and thinking by 35 per cent among people with early-stage Alzheimer’s Disease. The drug’s ability to slow down […]

Join Dementia Research volunteers help discover Alzheimer’s drug lecanemab

1 December 2022

The findings of a research study that discovered a treatment for early stage Alzheimer’s disease have been hailed as “momentous” by Alzheimer’s Research UK.  The new treatment, lecanemab, is the first drug to slow cognitive decline in people with early signs of the condition. The CLARITY-AD study enrolled 1,795 patients with early-stage Alzheimer’s globally, including Join […]

Investigating the impact of anti-inflammatory drugs on Alzheimer’s disease

18 October 2022

A research study exploring the impact specialist anti-inflammatory drugs have on Alzheimer’s disease symptoms is looking for volunteers in London, Plymouth, Guildford and Southampton. The EXploratory PLatform trial on Anti-INflammatory agents in Alzheimer’s Disease, or EXPLAIN-AD for short, will be evaluating the effectiveness and safety of anti-inflammatory agents on common Alzheimer’s symptoms – including memory, […]

Lecanemab – a potential new treatment for Alzheimer’s disease

28 September 2022

News that a potential treatment for early stage Alzheimer’s disease can slow cognitive decline is a significant development in dementia research. About the drug Lecanemab is an antibody that is designed to remove toxic beta-amyloid deposits; proteins that build up in the brains of people with Alzheimer’s disease. Following phase 3 clinical trials, pharmaceutical companies […]

Clinical study to assess potential Alzheimer’s drug

13 July 2022

There are almost one million people with dementia in the UK and the most common cause is Alzheimer’s disease. Researchers from University College London (UCL) with funding from the National Institute for Health and Care Research are testing a new approach to the treatment of mild Alzheimer’s disease in the DESPIAD (DEpletion of SaP in […]

1 2 3 4
get_header(); ?>

Archives

1 2 3 4